{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:21:33Z","timestamp":1725582093181},"reference-count":31,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.lpm.2010.03.028","type":"journal-article","created":{"date-parts":[[2010,9,16]],"date-time":"2010-09-16T08:56:02Z","timestamp":1284627362000},"page":"1058-1065","source":"Crossref","is-referenced-by-count":4,"title":["Pemphigo\u00efde bulleuse"],"prefix":"10.1016","volume":"39","author":[{"given":"Nathalie","family":"B\u00e9n\u00e9ton-Benhard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2010.03.028_bib0005","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1365-2133.2009.09300.x","article-title":"Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study","volume":"160","author":"Marazza","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.lpm.2010.03.028_bib0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archderm.1995.01690130050009","article-title":"Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions","volume":"131","author":"Bernard","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lpm.2010.03.028_bib0015","first-page":"7S7","article-title":"Incidence de la pemphigo\u00efde bulleuse","volume":"134","author":"Baricault","year":"2007","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.lpm.2010.03.028_bib0020","doi-asserted-by":"crossref","first-page":"a180","DOI":"10.1136\/bmj.a180","article-title":"Bullous pemphigoid and pemphigus vulgaris-incidence and mortality in the UK: population based cohort study","volume":"337","author":"Langan","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.lpm.2010.03.028_bib0025","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/archderm.141.6.691","article-title":"Prediction of survival for patients with bullous pemphigoid: a prospective study","volume":"141","author":"Joly","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lpm.2010.03.028_bib0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jaad.2007.08.010","article-title":"Bullous pemphigoid in infancy: clinical and epidemiologic characteristics","volume":"58","author":"Waisbourd-Zinman","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.lpm.2010.03.028_bib0035","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000106574","article-title":"Neurological disorders in patients with bullous pemphigoid","volume":"215","author":"Cordel","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.lpm.2010.03.028_bib0040","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1001\/archderm.1996.03890270044006","article-title":"Drugs associated with bullous pemphigoid. A case-control study","volume":"132","author":"Bastuji-Garin","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lpm.2010.03.028_bib0045","first-page":"7S7","article-title":"\u00c9tude \u00e9pid\u00e9miologique prospective des facteurs de risque de la pemphigo\u00efde bulleuse","volume":"134","author":"Bedane","year":"2007","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.lpm.2010.03.028_bib0050","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/archderm.134.9.1075","article-title":"Evaluation of clinical criteria for diagnosis of bullous pemphigoid","volume":"134","author":"Vaillant","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lpm.2010.03.028_bib0055","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000075040","article-title":"Clinical criteria for the diagnosis of bullous pemphigoid: a reevaluation according to immunoblot analysis of patient sera","volume":"208","author":"Joly","year":"2004","journal-title":"Dermatology"},{"key":"10.1016\/j.lpm.2010.03.028_bib0060","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1365-2133.2004.06082.x","article-title":"Evaluation of a BP180-NC16a enzyme-linked immunosorbent assay in the initial diagnosis of bullous pemphigoid","volume":"151","author":"Sakuma-Oyama","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.lpm.2010.03.028_bib0065","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1365-2230.2005.01937.x","article-title":"Collagen XVII\/BP180: a collagenous transmembrane protein and component of the dermoepidermal anchoring complex","volume":"30","author":"Powell","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.lpm.2010.03.028_bib0070","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12016-007-0030-y","article-title":"The pathophysiology of bullous pemphigoid","volume":"33","author":"Kasperkiewicz","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.lpm.2010.03.028_bib0075","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/archderm.134.4.465","article-title":"High risk of death in elderly patients with extensive bullous pemphigoid","volume":"134","author":"Roujeau","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lpm.2010.03.028_bib0080","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archderm.138.7.903","article-title":"Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age","volume":"138","author":"Rzany","year":"2002","journal-title":"Arch Dermatol"},{"issue":"346","key":"10.1016\/j.lpm.2010.03.028_bib0085","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa011592","article-title":"A comparison of oral and topical corticosteroids in patients with bullous pemphigoid","volume":"31","author":"Joly","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2010.03.028_bib0090","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/jid.2008.412","article-title":"A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study","volume":"129","author":"Joly","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.lpm.2010.03.028_bib0095","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1365-2133.2002.04835.x","article-title":"Guidelines for the management of bullous pemphigoid","volume":"147","author":"Wojnarowska","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.lpm.2010.03.028_bib0100","first-page":"CD002292","article-title":"Interventions for bullous pemphigoid","volume":"20","author":"Khumalo","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.lpm.2010.03.028_bib0105","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1365-2133.2008.08857.x","article-title":"Blistering skin disorders: an evidence-based update. Conference report","volume":"160","author":"Alexandroff","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.lpm.2010.03.028_bib0110","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1001\/archderm.143.12.1536","article-title":"A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid","volume":"143","author":"Beissert","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lpm.2010.03.028_bib0115","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1001\/archderm.138.9.1255","article-title":"Treatment of bullous pemphigoid by low-dose methotrexate associated with short-term potent topical steroids: an open prospective study of 18\u00a0cases","volume":"138","author":"Dereure","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lpm.2010.03.028_bib0120","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1001\/archderm.139.11.1506-b","article-title":"Methotrexate for bullous pemphigoid: preliminary study","volume":"139","author":"Bara","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lpm.2010.03.028_bib0125","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1001\/archderm.144.5.612","article-title":"A retrospective analysis of patients with bullous pemphigoid treated with methotrexate","volume":"144","author":"Kjellman","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lpm.2010.03.028_bib0130","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archderm.1994.01690060083010","article-title":"Nicotinamide and tetracycline therapy of bullous pemphigoid","volume":"130","author":"Fivenson","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lpm.2010.03.028_bib0135","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1067\/mjd.2001.116337","article-title":"Intravenous immunoglobulin therapy for patients with bullous pemphigoid unresponsive to conventional immunosuppressive treatment","volume":"45","author":"Ahmed","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.lpm.2010.03.028_bib0140","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archderm.136.2.174","article-title":"Serum levels of autoantibodies to BP180\u00a0correlate with disease activity in patients with bullous pemphigoid","volume":"136","author":"Schmidt","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lpm.2010.03.028_bib0145","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-4632.2008.03473.x","article-title":"Serum levels of autoantibodies to BP180\u00a0correlate with disease activity in patients with bullous pemphigoid","volume":"47","author":"Feng","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.lpm.2010.03.028_bib0150","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/archdermatol.2009.53","article-title":"Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort study","volume":"145","author":"Bernard","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lpm.2010.03.028_bib0155","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1365-2133.1997.tb03654.x","article-title":"Anti-BP180\u00a0autoantibodies as a marker of poor prognosis in bullous pemphigoid: a cohort analysis of 94\u00a0elderly patients","volume":"136","author":"Bernard","year":"1997","journal-title":"Br J Dermatol"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498210004264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498210004264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T03:50:08Z","timestamp":1544241008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498210004264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0755498210004264"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2010.03.028","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}